The global genital herpes treatment market share is expected to grow at a rapid pace and reach a valuation of more than US$ 2.14 billion by 2023. It is anticipated that the market would continue to develop at a substantial compound annual growth rate (CAGR) of 5.2% through 2033, finally reaching an estimated value of …